RxDoctor Payments Data

Kenneth Greenberg

Infectious Disease · Denver, CONPI 1972587228

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $114,370 of the $162,682 with a category attached, or 70.3%. 5 manufacturers reported payments, led by Gilead at 43.4% of the total. Reporting peaked in 2019 at $110,461 and has fallen 100.0% since, to $24 in 2024. Among infectious disease clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$162,682in general payments, 2019–2025

Across 240 payments — averaging $677.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$71K
  • Viiv Healthcare Company$50K
  • Merck$40K
  • Theratechnologies Inc.$2K
  • Hologic Sales And Service, LLC$24

What the payments were for

  • Consulting fees$27,73517%
  • Speaking & faculty fees$114,37070%
  • Travel & lodging$16,82410%
  • Food & beverage$3,7532%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead112$70,523
Viiv Healthcare Company70$50,142
Merck48$40,361
Theratechnologies Inc.9$1,633
Hologic Sales And Service, LLC1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$162,682 in reported general payments places this provider in the 95th percentile of 146 infectious disease providers in Colorado.

See all infectious disease providers in Colorado →

Other infectious disease in Denver

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →